Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morrison, C. CAR-T field booms as next-generation platforms attract big players. Nat Biotechnol 33, 571–572 (2015). https://doi.org/10.1038/nbt0615-571
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0615-571
- Springer Nature America, Inc.
This article is cited by
-
Evolution of CAR T-cell immunotherapy in terms of patenting activity
Nature Biotechnology (2019)
-
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
Molecular Cancer (2018)
-
Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide
Journal of Hematology & Oncology (2018)
-
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Journal of Hematology & Oncology (2017)
-
CAR-T cells forge ahead, Novartis reorganizes
Nature Biotechnology (2016)